je.st
news
Study finds that drug labelling change may add $4bn to US health care costs
2014-02-07 01:00:00| Packaging Gateway
The Food and Drug Administration's (FDA) recently proposed regulation affecting generic drug labelling may result in an estimated $4bn in additional US health care costs a year, according to an analysis by economic consulting firm Matrix Global Advis
Tags: add
change
health
care
Category:Industrial Goods and Services
Latest from this category |
All news |
||||||||||||||||||||||
|
|
||||||||||||||||||||||